acamprosate has been researched along with Recrudescence in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.63) | 18.7374 |
| 1990's | 12 (31.58) | 18.2507 |
| 2000's | 12 (31.58) | 29.6817 |
| 2010's | 12 (31.58) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Kroener, S; Luo, Y; Manepalli, R; Melugin, PR; Munoz, C; Nofal, A; Phensy, A; Pradhan, G; Wu, F | 1 |
| Bonnet, U; Dembski, N; Niederhofer, A; Niederhofer, E; Nyhuis, PW; Scherbaum, N; Schifano, F; Specka, M; Tenbergen, M | 1 |
| Fang, HM; Kroener, S; Melugin, PR; Pradhan, G; Weber, R; Wu, F | 1 |
| Beroun, A; Cały, A; Harda, Z; Nalberczak-Skóra, M; Pagano, R; Piechota, M; Radwanska, K; Ziółkowska, M | 1 |
| Minozzi, S; Rösner, S; Saulle, R | 1 |
| Braciszewski, JM; Falk, D; Kranzler, HR; O'Malley, SS; Stout, RL; Subbaraman, MS | 1 |
| Kufahl, PR; Olive, MF; Watterson, LR | 1 |
| Donoghue, K; Drummond, C; Elzerbi, C; Pilling, S; Saunders, R; Whittington, C | 1 |
| Saitz, R | 1 |
| Frohe, T; Kirouac, M; Maisto, SA; McCallion, E; Vowles, KE; Witkiewitz, K | 1 |
| Batra, A; Berner, M; Cichon, S; Frank, J; Heinz, A; Kiefer, F; Lemenager, T; Mann, K; Nöthen, MM; Richter, A; Rietschel, M; Smolka, MN; Spanagel, R; Treutlein, J; Wiedemann, K; Witt, SH; Wodarz, N; Zimmermann, US | 1 |
| Burtscheidt, W; Falkai, P; Franke, PE; Frommann, N; Gaebel, W; Jänner, M; Kuhlmann, T; Lieb, B; Maier, W; Ohmann, C; Radermacher, M; Scherbaum, N; Schütz, C; Wobrock, T; Wölwer, W | 1 |
| Bujarski, S; Lunny, K; O'Malley, SS; Ray, LA | 1 |
| O'Brien, CP | 1 |
| Littleton, J; Zieglgänsberger, W | 1 |
| Bachteler, D; Ciccocioppo, R; Danysz, W; Economidou, D; Spanagel, R | 1 |
| Demiralay, C; Jahn, H; Kiefer, F; Otte, C; Wiedemann, K; Wolf, K | 1 |
| Croissant, B; Diehl, A; Heinz, A; Klein, O; Mann, K; Nakovics, H; Zambrano, S | 1 |
| Jung, YC; Namkoong, K | 1 |
| Diehl, A; Jiménez-Arriero, MA; Kiefer, F; Klein, O; Rubio, G | 1 |
| Bonci, A; Bowers, MS; Chen, BT; Chou, JK; Gass, JT; Janak, PH; Olive, MF; Osborne, MP; See, RE | 1 |
| Littleton, J | 1 |
| Fischer, F; Fleischhacker, WW; Lesch, OM; Nimmerrichter, A; Oberbauer, H; Platz, T; Potgieter, A; Walter, H; Whitworth, AB | 1 |
| Mann, K; Sass, H; Soyka, M; Zieglgänsberger, W | 1 |
| Kotter, G; Preuss, U; Schütz, C; Soyka, M | 1 |
| Spanagel, R; Zieglgänsberger, W | 1 |
| Gavrilovic, M; Le Bon, O; Lehert, P; Lion, K; Pelc, I; Verbanck, P | 1 |
| Pelc, I | 1 |
| Kratzer, U; Schmidt, WJ | 1 |
| Corrigall, WA; Shaham, Y; Sillaber, I; Spanagel, R; Stewart, J; Zieglgänsberger, W | 1 |
| Mann, K | 1 |
| Brecht, JG; Schädlich, PK | 1 |
| Malerich, JA | 1 |
| Oberpichler-Schwenk, H | 1 |
| Yarborough, WH | 1 |
| Le, AD; McBride, WJ; Noronha, A | 1 |
| Fuchs, WJ; Riebenfeld, D | 1 |
| Bosimare, F; Chretien, P; Daoust, M; Hillemand, B; Lhuintre, JP; Moore, ND; Saligaut, C; Tran, G | 1 |
11 review(s) available for acamprosate and Recrudescence
| Article | Year |
|---|---|
Baclofen for alcohol use disorder.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Baclofen; Craving; Depression; Female; GABA-B Receptor Agonists; Humans; Male; Middle Aged; Patient Dropouts; Randomized Controlled Trials as Topic; Recurrence | 2018 |
The development of acamprosate as a treatment against alcohol relapse.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Humans; Recurrence; Taurine | 2014 |
The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Europe; Female; Global Health; Humans; Male; Middle Aged; Naltrexone; Randomized Controlled Trials as Topic; Recurrence; Taurine; Treatment Outcome | 2015 |
Research advances in the understanding and treatment of addiction.
Topics: Acamprosate; Alcohol Deterrents; Brain; Chronic Disease; Disease Progression; Humans; Naltrexone; Narcotics; Prognosis; Recurrence; Risk Factors; Substance-Related Disorders; Taurine | 2003 |
Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Behavior, Animal; Brain; Humans; Naltrexone; Narcotic Antagonists; Receptors, Glutamate; Recurrence; Taurine | 2003 |
Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Disulfiram; gamma-Aminobutyric Acid; Glutamine; Humans; Models, Biological; Models, Neurological; N-Methylaspartate; Naltrexone; Narcotic Antagonists; Neurons; Polymorphism, Genetic; Receptors, Opioid, mu; Recurrence; Taurine | 2006 |
Acamprosate in alcohol dependence: how does it work?
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Behavior Therapy; Clinical Trials as Topic; Combined Modality Therapy; Humans; Motivation; Recurrence; Taurine; Treatment Outcome | 1995 |
[Pharmacotherapy of alcoholism].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Clinical Trials as Topic; Dopamine Agents; Humans; Narcotic Antagonists; Psychotropic Drugs; Recurrence; Serotonin Agents; Taurine | 1996 |
Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes.
Topics: Acamprosate; Alcoholism; Animals; Behavior, Animal; Calcium Channels; Disease Models, Animal; Humans; Naltrexone; Narcotic Antagonists; Neurons; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Recurrence; Substance Withdrawal Syndrome; Synaptic Transmission; Taurine | 1997 |
[Alcoholism: relapse prevention].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Combined Modality Therapy; Humans; Medical History Taking; Psychotherapy; Recurrence; Surveys and Questionnaires; Taurine | 1997 |
The pharmacological treatment of alcohol dependence: needs and possibilities.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Clinical Trials as Topic; Humans; Recurrence; Taurine | 1996 |
12 trial(s) available for acamprosate and Recrudescence
| Article | Year |
|---|---|
Effectiveness of Psychoanalytic-Interactional Group Therapy vs. Behavioral Group Therapy in Routine Outpatient Treatment of Alcohol-Dependent Patients.
Topics: Acamprosate; Alcoholism; Cognitive Behavioral Therapy; Combined Modality Therapy; Disulfiram; Female; Humans; Male; Middle Aged; Naltrexone; Outpatients; Psychoanalytic Therapy; Psychotherapy, Group; Recurrence; Secondary Prevention; Taurine; Treatment Outcome | 2018 |
What happens when people discontinue taking medications? Lessons from COMBINE.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Behavior Therapy; Combined Modality Therapy; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Naltrexone; Patient Dropouts; Recurrence; Taurine | 2014 |
Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Behavior Therapy; Chronic Pain; Combined Modality Therapy; Female; Humans; Male; Naltrexone; Pain Measurement; Recurrence; Taurine; Treatment Outcome | 2015 |
The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Behavior Therapy; Combined Modality Therapy; Counseling; Female; Humans; Male; Middle Aged; Outpatients; Recurrence; Taurine; Treatment Outcome | 2011 |
The effects of drinking goal on treatment outcome for alcoholism.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Cognitive Behavioral Therapy; Female; Goals; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Recurrence; Taurine; Treatment Outcome | 2013 |
Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Double-Blind Method; Female; Humans; Leptin; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Recurrence; Taurine | 2005 |
A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Anticonvulsants; Carbamazepine; Female; Humans; Male; Middle Aged; Oxcarbazepine; Pilot Projects; Recurrence; Taurine | 2006 |
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.
Topics: Acamprosate; Adult; Alcoholism; Double-Blind Method; Ethanol; Female; Follow-Up Studies; Humans; Male; Recurrence; Taurine; Temperance; Time Factors; Treatment Outcome | 1996 |
Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence.
Topics: Acamprosate; Adult; Aged; Alcohol Drinking; Alcoholism; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Dropouts; Placebos; Recurrence; Survival Analysis; Taurine; Temperance; Treatment Outcome | 1996 |
Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study.
Topics: Acamprosate; Adolescent; Adult; Aged; Alcohol Deterrents; Alcoholism; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Libido; Male; Middle Aged; Recurrence; Taurine; Temperance; Treatment Outcome | 1997 |
[Acamprosate and psychosocial intervention. An integrative treatment approach for prevention of alcohol dependent patients in Switzerland].
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Psychotherapy; Quality of Life; Recurrence; Switzerland; Taurine; Temperance | 2002 |
Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics.
Topics: Acamprosate; Adult; Alcoholism; Clinical Trials as Topic; Double-Blind Method; Erythrocyte Indices; Female; gamma-Glutamyltransferase; Humans; Male; Middle Aged; Receptors, GABA-A; Recurrence; Substance Withdrawal Syndrome; Taurine | 1985 |
15 other study(ies) available for acamprosate and Recrudescence
| Article | Year |
|---|---|
The effects of acamprosate on prefrontal cortical function are mimicked by CaCl2 and they are influenced by the history of alcohol exposure.
Topics: Acamprosate; Animals; Calcium; Calcium Chloride; Ethanol; Mice; Prefrontal Cortex; Recurrence; Taurine | 2022 |
Calcium chloride mimics the effects of acamprosate on cognitive deficits in chronic alcohol-exposed mice.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Attention; Calcium Chloride; Central Nervous System Depressants; Cognition; Cognitive Dysfunction; Ethanol; Male; Mice; Recognition, Psychology; Recurrence | 2018 |
Generation of silent synapses in dentate gyrus correlates with development of alcohol addiction.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Animals; Central Nervous System Depressants; Cues; Dendritic Spines; Dentate Gyrus; Disease Progression; Ethanol; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Neurons; Patch-Clamp Techniques; Receptors, AMPA; Recurrence; Synapses | 2018 |
[Acamprosate and naltrexone: similar efficacy for relapse].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Humans; Naltrexone; Narcotic Antagonists; Recurrence; Taurine | 2014 |
Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Alcohols; Atrial Natriuretic Factor; Female; GATA4 Transcription Factor; Gene Dosage; Genetic Association Studies; Genetic Variation; Humans; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Randomized Controlled Trials as Topic; Recurrence; Risk; Taurine | 2011 |
The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Animals; Conditioning, Operant; Cues; Cyclopentanes; Extinction, Psychological; Injections, Intraperitoneal; Male; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Recurrence; Taurine | 2005 |
Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcoholism; Combined Modality Therapy; Double-Blind Method; Female; Follow-Up Studies; Genetic Predisposition to Disease; Germany; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Psychotherapy; Randomized Controlled Trials as Topic; Recurrence; Spain; Taurine; Treatment Outcome | 2008 |
Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats.
Topics: Acamprosate; Alcohol Deterrents; Animals; Behavior, Addictive; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Cues; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Recurrence; Self Administration; Taurine | 2007 |
The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.
Topics: Acamprosate; Alcohol Deterrents; Analgesics, Opioid; Animals; Conditioning, Psychological; Drug Interactions; Male; Morphine; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Recurrence; Spatial Behavior; Substance Withdrawal Syndrome; Taurine | 1998 |
Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress.
Topics: Acamprosate; Animals; Drug Interactions; Drug Tolerance; Food Deprivation; Heroin; Heroin Dependence; Male; Morphine; Narcotics; Rats; Rats, Sprague-Dawley; Recurrence; Self Administration; Stress, Physiological; Taurine | 1998 |
The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Cost-Benefit Analysis; Economics, Pharmaceutical; Germany; Humans; Models, Economic; Recurrence; Taurine | 1998 |
Prevention of relapse in alcohol dependence.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Behavior Therapy; Disulfiram; Family; Humans; Naltrexone; Narcotic Antagonists; Recurrence; Self-Help Groups; Taurine | 1999 |
[Efficient prevention of relapse with acamprosate].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Humans; Recurrence; Taurine | 2000 |
Addiction medicine for the primary care physician.
Topics: Acamprosate; Alcohol Deterrents; Alcoholics Anonymous; Alcoholism; Antidepressive Agents, Tricyclic; Disulfiram; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Primary Health Care; Recurrence; Risk Factors; Severity of Illness Index; Substance-Related Disorders; Taurine; Treatment Outcome | 2001 |
Central nervous system mechanisms in alcohol relapse.
Topics: Acamprosate; Alcoholism; Animals; Behavior; Central Nervous System; Corticotropin-Releasing Hormone; Disease Models, Animal; Environment; Ethanol; Food Preferences; Humans; Mice; Neurons; Rats; Recurrence; Reinforcement, Psychology; Stress, Physiological; Taurine | 2002 |